Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q3 2020 · 10-Q
Revenue$2.19B$2.19B−4.6% vs Q3 2019 Net Income$46.08M$46.08M+3,664.8% vs Q3 2019 EPS Diluted$0.76$0.76+3,700.0% vs Q3 2019 Gross Profit$344,339,000+22.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$117,739,000+6.9% Free Cash Flowderived$104,794,000+4.9% Margins · derivedGross margin15.7%+3.5 pt vs Q3 2019
Operating margin3.5%+2.3 pt vs Q3 2019
Net margin2.1%+2.1 pt vs Q3 2019
ended Sep 30, 2020 · filed Nov 3, 2020 · 34 d after period end